Haemonetics Corporation (HAE) EPS Estimated At $0.54

October 13, 2018 - By whatsonthorold

Haemonetics Corporation (NYSE:HAE) LogoInvestors sentiment increased to 1.24 in Q2 2018. Its up 0.06, from 1.18 in 2018Q1. It is positive, as 25 investors sold Haemonetics Corporation shares while 84 reduced holdings. 64 funds opened positions while 71 raised stakes. 46.74 million shares or 6.30% less from 49.88 million shares in 2018Q1 were reported.
Martingale Asset Lp reported 0.1% stake. Price T Rowe Associate Md invested 0.01% of its portfolio in Haemonetics Corporation (NYSE:HAE). Dupont Cap, Delaware-based fund reported 40,353 shares. Sigma Planning Corporation accumulated 3,194 shares. Amalgamated Natl Bank stated it has 0.02% of its portfolio in Haemonetics Corporation (NYSE:HAE). Wagner Bowman Mgmt has invested 0.06% in Haemonetics Corporation (NYSE:HAE). Morgan Stanley reported 372,062 shares. 43,096 were reported by Comerica Natl Bank. Panagora Asset invested in 734,672 shares. Wisconsin-based Convergence Inv Prns Ltd Liability Corporation has invested 0.49% in Haemonetics Corporation (NYSE:HAE). Mutual Of America Management Ltd Co reported 0.08% in Haemonetics Corporation (NYSE:HAE). Arrowstreet Limited Partnership reported 439,282 shares. Bogle Invest Mngmt Limited Partnership De, Massachusetts-based fund reported 17,586 shares. Advsr Asset Management Incorporated holds 40,379 shares. Vanguard Grp Inc Inc holds 0.02% in Haemonetics Corporation (NYSE:HAE) or 5.51 million shares.

Since June 6, 2018, it had 0 insider purchases, and 10 sales for $5.73 million activity. 3,794 shares valued at $360,766 were sold by Goldstein Dan on Wednesday, June 6. The insider Burke William P. Mr. sold 6,687 shares worth $616,341. Shares for $16,970 were sold by Ryding Neil Mr. on Thursday, June 7. On Monday, September 17 the insider GRANADILLO PEDRO P sold $3.45 million. Another trade for 4,890 shares valued at $548,609 was sold by Scanlan Jacqueline. $42,378 worth of Haemonetics Corporation (NYSE:HAE) was sold by Basil Michelle L.

Analysts expect Haemonetics Corporation (NYSE:HAE) to report $0.54 EPS on November, 6.They anticipate $0.06 EPS change or 12.50 % from last quarter’s $0.48 EPS. HAE’s profit would be $27.91M giving it 49.30 P/E if the $0.54 EPS is correct. After having $0.59 EPS previously, Haemonetics Corporation’s analysts see -8.47 % EPS growth. The stock increased 0.08% or $0.08 during the last trading session, reaching $106.48. About 711,724 shares traded or 34.45% up from the average. Haemonetics Corporation (NYSE:HAE) has risen 158.45% since October 14, 2017 and is uptrending. It has outperformed by 142.83% the S&P500.

Haemonetics Corporation (NYSE:HAE) Ratings Coverage

Among 2 analysts covering Haemonetics (NYSE:HAE), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Haemonetics had 3 analyst reports since May 9, 2018 according to SRatingsIntel. The stock of Haemonetics Corporation (NYSE:HAE) earned “Overweight” rating by Morgan Stanley on Wednesday, August 8. The rating was maintained by Morgan Stanley on Wednesday, May 9 with “Overweight”. The stock has “Buy” rating by Jefferies on Thursday, June 14.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company has market cap of $5.50 billion. The firm operates through five divisions: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It has a 248.79 P/E ratio. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma clients to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection and processing products.

Haemonetics Corporation (NYSE:HAE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News